Free Trial

Jaguar Animal Health (JAGX) Competitors

Jaguar Animal Health logo
$2.30 +0.13 (+5.99%)
Closing price 04:00 PM Eastern
Extended Trading
$2.30 0.00 (0.00%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JAGX vs. PRPH, THAR, ASBP, NAII, CLRB, EDSA, IXHL, ABP, AYTU, and NRSN

Should you be buying Jaguar Animal Health stock or one of its competitors? The main competitors of Jaguar Animal Health include ProPhase Labs (PRPH), Tharimmune (THAR), Aspire Biopharma (ASBP), Natural Alternatives International (NAII), Cellectar Biosciences (CLRB), Edesa Biotech (EDSA), Incannex Healthcare (IXHL), Abpro (ABP), Aytu BioPharma (AYTU), and NeuroSense Therapeutics (NRSN). These companies are all part of the "pharmaceutical products" industry.

Jaguar Animal Health vs. Its Competitors

ProPhase Labs (NASDAQ:PRPH) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

In the previous week, ProPhase Labs and ProPhase Labs both had 2 articles in the media. Jaguar Animal Health's average media sentiment score of 0.64 beat ProPhase Labs' score of 0.00 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company Overall Sentiment
ProPhase Labs Neutral
Jaguar Animal Health Positive

Jaguar Animal Health has higher revenue and earnings than ProPhase Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ProPhase Labs$6.77M3.14-$53.36M-$1.26-0.41
Jaguar Animal Health$11.69M0.43-$38.49MN/AN/A

ProPhase Labs has a beta of -0.62, meaning that its stock price is 162% less volatile than the S&P 500. Comparatively, Jaguar Animal Health has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500.

ProPhase Labs has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -344.16%. ProPhase Labs' return on equity of -262.42% beat Jaguar Animal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
ProPhase LabsN/A -262.42% -76.48%
Jaguar Animal Health -344.16%-660.18%-77.42%

Jaguar Animal Health has a consensus price target of $60.00, suggesting a potential upside of 2,508.70%. Given Jaguar Animal Health's stronger consensus rating and higher probable upside, analysts clearly believe Jaguar Animal Health is more favorable than ProPhase Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ProPhase Labs
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Jaguar Animal Health
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

9.5% of ProPhase Labs shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 9.6% of ProPhase Labs shares are owned by insiders. Comparatively, 4.6% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Jaguar Animal Health beats ProPhase Labs on 8 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAGX vs. The Competition

MetricJaguar Animal HealthMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.72M$2.65B$6.14B$10.65B
Dividend YieldN/A56.72%5.66%4.70%
P/E RatioN/A23.7585.8427.65
Price / Sales0.43782.57621.60138.35
Price / CashN/A177.3038.3262.20
Price / Book0.195.6413.066.79
Net Income-$38.49M$32.78M$3.30B$275.88M
7 Day Performance4.07%6.31%4.81%2.64%
1 Month Performance19.17%13.80%9.99%9.13%
1 Year Performance-92.87%2.75%85.28%35.89%

Jaguar Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JAGX
Jaguar Animal Health
2.2386 of 5 stars
$2.30
+6.0%
$60.00
+2,508.7%
-93.3%$4.72M$11.69M0.0050Analyst Forecast
High Trading Volume
PRPH
ProPhase Labs
0.3595 of 5 stars
$0.44
-1.1%
N/A-77.8%$18.39M$5.59M-0.35130Analyst Forecast
Gap Up
THAR
Tharimmune
2.5079 of 5 stars
$2.90
-4.0%
$17.00
+486.2%
+56.7%$17.83MN/A-0.482News Coverage
Analyst Forecast
ASBP
Aspire Biopharma
N/A$0.31
-13.0%
N/AN/A$17.80MN/A0.00N/AAnalyst Forecast
Gap Down
NAII
Natural Alternatives International
1.2652 of 5 stars
$2.91
+1.0%
N/A-40.2%$17.79M$125.48M-1.28290Analyst Forecast
CLRB
Cellectar Biosciences
2.399 of 5 stars
$5.41
-2.0%
$375.00
+6,831.6%
-92.5%$17.62MN/A-0.2710Analyst Forecast
EDSA
Edesa Biotech
3.2524 of 5 stars
$2.45
-1.6%
$5.00
+104.1%
-36.2%$17.52MN/A-1.8620Positive News
Analyst Forecast
Gap Down
High Trading Volume
IXHL
Incannex Healthcare
0.7637 of 5 stars
$0.52
-12.8%
N/A-72.3%$17.51M$98K-0.433News Coverage
Analyst Forecast
Short Interest ↓
High Trading Volume
ABP
Abpro
3.3081 of 5 stars
$0.26
+17.9%
$4.00
+1,457.0%
N/A$17.47M$183K0.0015Analyst Forecast
Gap Up
High Trading Volume
AYTU
Aytu BioPharma
3.7693 of 5 stars
$1.71
-1.7%
$9.17
+436.1%
+0.9%$17.25M$66.38M-0.61160
NRSN
NeuroSense Therapeutics
2.2712 of 5 stars
$1.25
+0.8%
$14.00
+1,020.0%
+0.0%$16.95MN/A-2.3110News Coverage
Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:JAGX) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners